药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sinecatechins
Norgestrienone
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Norgestrienone.
Sinecatechins
Chlormadinone
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Chlormadinone.
Sinecatechins
Ormeloxifene
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Ormeloxifene.
Sinecatechins
Lynestrenol
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Lynestrenol.
Sinecatechins
Gestrinone
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Gestrinone.
Sinecatechins
Norgestrel
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Norgestrel.
Sinecatechins
Norethynodrel
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Norethynodrel.
Sinecatechins
Dienogest
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Dienogest.
Sinecatechins
Gestodene
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Gestodene.
Sinecatechins
Cyproterone acetate
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Cyproterone acetate.
Sinecatechins
Drospirenone
The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Drospirenone.
Sinecatechins
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Bamet-UD2 resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sinecatechins
Aluminum chloride
Aluminum chloride can cause a decrease in the absorption of Bamet-UD2 resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sinecatechins
Relcovaptan
The risk or severity of adverse effects can be increased when Relcovaptan is combined with Bamet-UD2.
Sinecatechins
Buflomedil
The risk or severity of adverse effects can be increased when Buflomedil is combined with Bamet-UD2.
Sinecatechins
Linsidomine
The risk or severity of adverse effects can be increased when Linsidomine is combined with Bamet-UD2.
Sinecatechins
Cloricromen
The risk or severity of adverse effects can be increased when Cloricromen is combined with Bamet-UD2.
Sinecatechins
Picotamide
The risk or severity of adverse effects can be increased when Picotamide is combined with Bamet-UD2.
Sinecatechins
Ramatroban
The risk or severity of adverse effects can be increased when Ramatroban is combined with Bamet-UD2.
Sinecatechins
Hydroxytyrosol
The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Bamet-UD2.